Introduction
============

The risk of developing exercise-induced bronchoconstriction (EIB) is increased among athletes, particularly those practicing at the elite level.[@b1-oajsm-2-041]--[@b5-oajsm-2-041] The exact mechanisms behind this are still under debate, however the intensity of physical activity and atopy in athletes seem to be the main factors.[@b5-oajsm-2-041] The diagnosis of EIB in athletes is made according to reported symptoms, physical examination and the variability of lung function spontaneously.[@b6-oajsm-2-041] Competing athletes frequently report the presence of respiratory symptoms in relation to exercise. Currently questionnaires and surveys remain the most frequently used method of assessment. The data collected by these methods may not however always accurately reflect the respiratory condition of the participating athlete. Indeed, self-reported asthma, physician, diagnosed EIB-and respiratory symptoms, all of which are frequently recorded in surveys and questionnaires, have the disadvantage of relying on subjective perception.[@b7-oajsm-2-041] Among the objective methods for evaluating the respiratory condition of athletes, the most common is the change in the forced expiratory volume in the first second (FEV~1~) before and after exercise. A fall of more than 10% or 15% in FEV~1~ after exercise is one proposed indicator of EIB.[@b7-oajsm-2-041]

The aim of the present study was to compare the incidence of exercise-induced bronchoconstriction among Tunisian elite athletes by using the objective method of spirometry before and after exercise, and a subjective method consisting of a medical history questionnaire, and to discuss the possible causes and implications of any discrepancy.

Methods
=======

This study was conducted over 10 different testing sessions. The tests were performed in the morning (between 9 am and 11 am); the mean temperature and relative humidity were 10 ± 4°C (range 6--14°C) and 45.6 ± 12% (range 38%--55%).

Prior to exercise, a familiarization session was conducted to collect demographic information via a questionnaire, give information on the study protocol and the use of spirometry, and to introduce subjects to the investigators.

Subjects
--------

The 107 elite athletes (63 males and 44 females, mean age 20.6 ± 1.8 years; range 17--23 years, see [Table 1](#t1-oajsm-2-041){ref-type="table"}) were divided into groups according to the type of training environment: 42 athletes trained and competed outdoors and 65 trained and competed indoors. No subjects reported upper-respiratory tract infection at the time of the study. At that time, they had been involved in their current sport for a mean of 8.5 years (range 7--11 years) and trained regularly (mean weekly training duration: 18.3 ± 1.9 hours per week, range 16--21 hours per week). The outdoors activities included: soccer (n = 12), tennis (n = 4), and athletics (n = 26); high jump, decathlon, javelin, and middle to long-distance runners (1500 m weight-lifting (n = 7), taekwondo (n = 10), judo (n = 12), handball (n = 14), basketball (n = 15), and gymnastics (n = 7).

Athletes enrolled in the present study were informed in detail about the protocol and the aims of the study. Each participant responded to a questionnaire about respiratory function and underwent a spirometry test at rest and after 8 minutes running. The research protocol, which was in accordance with the declaration of Helsinki, was approved by the Research Ethics Committee of the Faculty of Medicine, University of Sousse, Tunisia.

Questionnaire: symptoms and medical history
-------------------------------------------

All athletes were asked to complete a medical history questionnaire administered in French. The questionnaire was designed by the United States Olympic Committee (USOC) Sports Medicine Division[@b8-oajsm-2-041] and was translated from English to French by an epidemiology expert before being further verified by back-translation from French to English by an independent researcher. It was the same as that used by Weiler et al[@b8-oajsm-2-041] to determine how many of the US athletes who participated in the 1998 Olympic Winter Games in Nagano and in the 1996 Olympic summer Games in Atlanta had a previous history of asthma, had symptoms suggestive of asthma, or had indicated taking a medication used to treat asthma.

FEV~1~ measurements: lung function test
---------------------------------------

Lung function tests were carried out on a portable spirometer (Auto Spiro Pal; Minato Medical Science Co, Osaka, Japan). The athletes performed the baseline test three times and the highest result was taken into consideration. The subjects were seated comfortably; they were instructed to take a full breath in, then to close the lips around the mouth tube and blow out as hard and fast as possible. Inspiration had to be full and unhurried, and tested expiration had to be continued without pause. The technique was demonstrated to every subject and the result was expressed in liters per second. The subjects were diagnosed with asthma if any of the post-exercise FEV~1~ values was at least 15% lower than the pre-exercise FEV~1~ measurement. This level of 15% was chosen according to the recommendations of the American Thoracic Society suggesting that this level is optimal for} outdoor conditions.[@b9-oajsm-2-041]

FEV~1~ was measured at 0, 5, 10, 15, 20, and 30 minutes after completion of exercise.

Exercise performance
--------------------

The athletes ran for 8 minutes at 80%--85% of the estimated maximum heart rate (HRmaxTheo).

The exercise was performed without any prior warm-up and subjects ran in groups of four around an outdoor track. Throughout the run, subjects were equipped with portable heart rate monitors (Polar S610, Oy, Kempele, Finland) set to record the heart rate (HR) at 5-second intervals. Before the session, each subject was informed of the range of HR at which to run according to the HRmaxTheo, calculated as described by Crapo et al[@b10-oajsm-2-041]: HRmaxTheo = (220-age).

Statistical analysis
--------------------

Results concerning respiratory symptoms and nociceptive sensations were expressed as the number and percentage of athletes. Number of years of training and hours of training per week were expressed as mean ± standard deviation (SD). A Chi-square test was used to analyze the data from the questionnaire. Student's *t*-test for independent samples was used to determine the differences among the means of group variables. Sensitivity and specificity were calculated for the questionnaire to identify EIB, and the kappa coefficient was also calculated to show the degree of agreement. Statistical significance was fixed at the *P* \< 0.05 level.

Results
=======

All of the recruited 107 athletes (mean age 20.6 ± 1.8 years; range 17--23 years) completed the questionnaire and the spirometric and running tests. The clinical characteristics of the study groups are given in [Table 1](#t1-oajsm-2-041){ref-type="table"}.

Post-exercise spirometry tests revealed the presence of EIB in 13% of the athletes (14 out of the 107). When individual data for each subject were pooled and analyzed by parametric statistical analysis, no significant intergroup differences were observed in demographic variables or in pre-exercise FEV~1~ ( [Table 1](#t1-oajsm-2-041){ref-type="table"}). Intergroup comparison indicated that athletes with EIB had significantly lower post-exercise FEV~1~ than the athletes not showing EIB (*P* \< 0.001) with a respective drop in FEV~1~ of 17.05 ± 2.60 and 3.99 ± 3.77 compared with values recorded prior to exercise.

The medical history questionnaire ([Table 2](#t2-oajsm-2-041){ref-type="table"}) revealed that about 0.9% (1 out of 107) of the athletes had an allergy to some medication (Q 1) and almost 4.6% (5 out of 107) had an allergy to insect bites or food (Q 2). Running causing chest symptoms (Q 8) was reported by 4.6% (5 out of 107) of the athletes, chest tightness by 4.6% (5 out of 107) and wheezing by 1.8% (2 out of 107). Among the 107 athletes, 1.8% (2 out of 107) reported having been previously diagnosed with asthma or EIB (Q 11).

The sensitivity and specificity of self-reported symptoms for EIB diagnosis were 35.71% and 96.77%, respectively.

The agreement reached between the two methods (tests) using the kappa coefficient corresponds to 42% of the maximum.

Discussion
==========

The major finding of the present study is that 13% (14 out of 107) of the Tunisian elite athletes fulfilled the diagnostic criteria of EIB despite only 1.8% of these athletes reporting having been previously diagnosed with EIB and taking prescribed medications on a permanent basis (steroids and anti-inflammatories). The use of a self-reporting respiratory symptoms questionnaire alone to evaluate asthma may lead to a number of false negative and false positive diagnoses. Surprisingly, in the present study, very few athletes reported exercise-induced breathlessness, or symptoms of wheezing and chest tightness. This could be explained by "the fact that they do not perceive, do not recognize or do not want to recognize these respiratory sensations." Another possible reason for athletes ignoring this disorder is the fear of being eliminated from the team or not being selected for events.

Curiously, a significant number of nonasthmatic athletes experienced symptoms such as breathing difficulties on completion of the exercise, perhaps due to exercise intensity. However, the questions concerning respiratory symptoms did not allow a clear distinction to be made between asthma and its absence in athletes. In addition, a large proportion of athletes with EIB (9/14 \[65%\]) indicated no respiratory symptoms associated with exercise. This could be because they did not recognize these respiratory sensations or that their asthma is so well controlled that the sensation of respiratory discomfort has gone. Another possible reason may be that these athletes try to ignore the condition though fear of being removed from the team or fear of not being selected for competition. As pointed out by Rundell et al[@b11-oajsm-2-041] the advantage of using questionnaires is that they recruit a large number of subjects, they save a lot of time, and they are less expensive compared to other means of diagnosis. However, the use of questionnaires may lead to unreliable diagnoses.

When we compared the prevalence of EIB in athletes obtained by subjective and objective methods, we noticed a dramatic difference. This same discrepancy, however, seems less marked among Olympians than other categories of athletes. Using subjective methods, Fitch,[@b12-oajsm-2-041] Voy,[@b13-oajsm-2-041] and Weiler and Ryan[@b1-oajsm-2-041] diagnosed asthma in 9.3%, 11.2%, and 15.3% of the same group of Summer Games Olympic athletes, respectively. Voy[@b13-oajsm-2-041] found an incidence of 14.2% using objective measures of EIB.

In this regard, Langdeau and Boulet[@b14-oajsm-2-041] and Melani et al[@b15-oajsm-2-041] indicated a large disparity between the two methods. Indeed, various studies have shown that the prevalence of EIB as determined by the questionnaire approach rarely exceeds 20%, while this percentage is largely exceeded when the studies use means of group variables respiratory testing.

The sensitivity and specificity of self-reported symptoms for EIB diagnosis were 35.71% and 96.77%, respectively. This indicates that the self-reported symptoms have been shown to have only a low sensitivity but high specificity for EIB in elite athletes, and are thus not recommended in the athlete with pure EIB. Rundell et al[@b11-oajsm-2-041] and Thole et al[@b16-oajsm-2-041] demonstrated a poor sensitivity (\< 62%) and poor specificity (\< 86%) of detection of respiratory symptoms in athletes with EIB. Our results are in accordance with others showing that EIB can be asymptomatic.[@b17-oajsm-2-041]--[@b19-oajsm-2-041] Rundell et al[@b18-oajsm-2-041] found that at least one symptom is present in 91% of the athletes with EIB compared with only 48% of those without. In another study,[@b11-oajsm-2-041] the same authors found symptoms present in 61% of the athletes diagnosed as having asthma by lung function testing and in only 41% of those in whom the testing was negative.

Collectively, these studies show the unreliable nature of data obtained solely from questionnaires based on clinical symptoms for the assessment of EIB. Indeed, while questionnaires are useful tools in assessing the prevalence of respiratory symptoms in a population they do not take into account inter-individual differences in levels of perception of the symptoms or tolerance. These results also further explain why the use of a self-reporting questionnaire on respiratory symptoms to evaluate EIB may lead to a number of false negative and false positive diagnoses.[@b11-oajsm-2-041] According to Parsons,[@b4-oajsm-2-041] patient history and examination have limitations, the history often being nonspecific and the examination at rest being normal. There are also many conditions that mimic EIB presenting with similar symptoms, such as vocal cord dysfunction, cardiac arrhythmias, cardiomyopathies, and gastroesophageal reflux disease. In the present study, and surprisingly, very few athletes experienced exercise-induced breathlessness, wheezing, or chest tightness. This could be explained by the fact that they do not perceive, do not recognize, or do not want to recognize these respiratory sensations.[@b20-oajsm-2-041] Another possible reason for the athletes to ignore this disorder is their fear of being eliminated from the team or not being selected for events. Kappa coefficient corresponds to 42% of the maximum, which indicates a moderate agreement between the two tests. Langdeau and Boulet[@b7-oajsm-2-041] proposed a number of reasons for the discrepancy between objective and subjective test results, the first of which is that the increased incidence of heightened airway responses to inhaled constrictor agents observed in athletes may not only suggest the presence of an abnormal condition such as EIB, but could be the reflection of a "normal" response to a "supranormal" stimulus such as high-intensity exercise. It is possible, as previously suggested by Anderson and Holzer[@b27-oajsm-2-041] in a thorough review of exercise-induced bronchoconstriction, that the humidifying process taking place in the small airways, in response to exercise, could lead to airway edema and/or mucus secretion and that in combination with the ''physiological'' shortening of smooth muscles would amplify the airway narrowing with a resulting reduction in FEV~1~. The second factor is that high-intensity exercise causes asymptomatic airway hyper-responsiveness. Finally, the authors reported that the low incidence observed in athletes could also suggest that EIB is under-diagnosed when questionnaires are used, as they rely on self-reporting of symptoms that could be ignored or not well perceived by athletes. The phenomenon of under-recognition of EIB can also exist even with a physician-made diagnosis of EIB, as nonspecialist physicians rely primarily on respiratory symptoms or treatment trials to make the diagnosis of EIB.

One of the limitations of the present study is the absence of the eucapnic voluntary hyperventilation (EVH) challenge test recommended by the International Olympics Committee and shown to have a high specificity for EIB.[@b21-oajsm-2-041] EVH has also been shown to be more sensitive at detecting EIB than the methacholine challenge[@b22-oajsm-2-041] or field or laboratory-based exercise testing.[@b21-oajsm-2-041] EVH can also be performed successfully and safely to investigate EIB in patients other than elite athletes.[@b23-oajsm-2-041] Because of the wide differential diagnosis of exertional respiratory complaints, the diagnosis of EIB based on history and self-reported symptoms alone can only be considered as being inaccurate.[@b10-oajsm-2-041],[@b24-oajsm-2-041],[@b25-oajsm-2-041] Should health care providers rely on history alone to make a diagnosis of EIB, evidence has shown that they will be mistaken in over 50% of cases. A second limitation is the number of subjects (n = 107), which is lower than the theoretical number needed to study the prevalence of EIB in the studied population. The formula[@b11-oajsm-2-041] yields a sample size of 138, based on a 10% expected prevalence of EIB, a desired precision for the calculated results of 5%, and a desired confidence level of *P* \< 0.05. The actual number of 107 provides only 77% of the optimal sample size.

We believe that athletes should be informed of the heightened risk of developing EIB, as a large number appear unaware that they are affected by the condition. Furthermore, to adequately assess airway function in athletes, particularly with regard to the potential risk of developing symptomatic asthma, objective methods are preferred. A heavier reliance on such methods should lead to a better identification of airway dysfunction in athletes with clinical suspicion of EIB.

Conclusion
==========

The findings from this study show a discrepancy in the incidence of EIB among Tunisian athletes as detected by objective (13%) and subjective (1.8%) tests. We suggest that the presence of EIB can be difficult to diagnose clinically given the lack of specific symptoms and the frequent misinterpretation of vigorous exercise-induced manifestations.

Questionnaires are useful tools when evaluating the prevalence of respiratory symptoms in a population. However, they do not take into consideration the varying levels of perception and/or tolerance to symptoms among individuals. A complete history and physical examination should be performed on each athlete with respiratory complaints associated with exercise. However, because of the limitations and poor predictive value of patient history in the evaluation of EIB, objective diagnostic testing should be performed when EIB is suspected.
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###### 

Mean ± SD anthropometric and spirometric variables of the studied group

  Characteristics                Means ± SD   Range
  ------------------------------ ------------ ------------
  Number of athletes             107          
  Age (years)                    20.6 ± 1.8   17--23
  Height (cm)                    170 ± 10     159--191
  Body mass (kg)                 61.3 ± 6.8   48--75
  FEV~1~ (L)                     4.0 ± 0.7    2.66--5.28
  Relative value of FEV~1~ (%)   124 ± 14     85--149
  FEF25--75 (%)                  88.7 ± 11    76--118

**Abbreviations:** FEF25--75, forced expiratory flow through the midportion of vital capacity; FEV~1~, forced expiratory volume in the one second; relative value of FEV~1~, percentage of theoretical values;[@b26-oajsm-2-041] SD, standard deviation.

###### 

Questions asked in the medical history questionnaire

  Question                                                                                                                                                Yes/total   \% (out of 107)
  ------------------------------------------------------------------------------------------------------------------------------------------------------- ----------- -----------------
  1\. Are you allergic to any medicine (eg, aspirin, penicillin, sulfa)?                                                                                  1/107       0.9
  2\. Are you allergic to any insect bites/stings or do you have any food allergies?                                                                      5/107       4.7
  3\. Do you take any medications (over the counter, herbs, supplements, vitamins)?                                                                       8/107       7.5
  4\. Do you ever have itching of the nose or throat or sneezing spells?                                                                                  15/107      14
  5\. Do you ever have chest tightness?                                                                                                                   5/107       4.7
  6\. Do you ever have wheezing?                                                                                                                          2/107       1.8
  7\. Do you ever have itchy eyes?                                                                                                                        13/107      12.2
  8\. Does running ever cause chest tightness or cough or wheezing or prolonged shortness of breath?                                                      5/107       4.7
  9\. Have you ever had chest tightness, cough, wheezing, asthma, or other chest (lung) problems, which made it difficult for you to perform in sports?   13/107      12.2
  10\. Do you take any prescribed medications on a permanent or semi-permanent basis (steroids, birth control pills, anti-inflammatories, antibiotics)?   3/107       2.8
  11\. Have you ever been told that you have (had) asthma or exercise-induced asthma?                                                                     2/107       1.8
  12\. Do you have trouble breathing or do you cough during or after activity?                                                                            2/107       1.8
  13\. Have you ever missed school, work, or practice because of chest tightness or cough or wheezing or prolonged shortness of breath?                   2/107       1.8
  14\. If you have been told you have asthma, what medications have you taken?                                                                            2/107       1.8
  15\. Do you have or have you ever had lung disease (pneumonia)?                                                                                         3/107       2.8
  16\. List current medications.                                                                                                                          2/107       1.8
